Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LIQUICHEK ANTI-SS-B CONTROL, POSITIVE, CATALOG #113

K-Number: K024232 · 2003-01-17

ApplicantBio-Rad
Decision Date2003-01-17
Product CodeLKJ
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

LIQUICHEK ANTI-SS-B CONTROL, POSITIVE, CATALOG #113 is the device name listed in this FDA 510(k) record. The listed applicant is Bio-Rad. It received FDA 510(k) clearance on 2003-01-17 under 510(k) number K024232. The device is classified under product code LKJ. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LIQUICHEK ANTI-SS-B CONTROL, POSITIVE, CATALOG #113?

LIQUICHEK ANTI-SS-B CONTROL, POSITIVE, CATALOG #113 is a medical device that received FDA 510(k) clearance on 2003-01-17. The listed applicant is Bio-Rad. The 510(k) number is K024232.

When did LIQUICHEK ANTI-SS-B CONTROL, POSITIVE, CATALOG #113 receive FDA 510(k) clearance?

LIQUICHEK ANTI-SS-B CONTROL, POSITIVE, CATALOG #113 received FDA 510(k) clearance on 2003-01-17, under 510(k) number K024232.

Who is the listed applicant for LIQUICHEK ANTI-SS-B CONTROL, POSITIVE, CATALOG #113?

The FDA 510(k) record lists Bio-Rad as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LIQUICHEK ANTI-SS-B CONTROL, POSITIVE, CATALOG #113?

The FDA product code for LIQUICHEK ANTI-SS-B CONTROL, POSITIVE, CATALOG #113 is LKJ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Bio-Rad as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K171061MRSASelect IIK122187VRESELECT CULTURE MEDIUMK103684VRESELECT CULTURE MEDIUMK093678PLATELIA ASPERGILLUS EIA MODEL 62793K100589MRSA SELECT - SKIN AND SOFT TISSUE WOUND SPECIMENSK081362PLATELIA LYME IGM

View all 319 devices →

Related Devices (Code: LKJ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K210902EliA Ro52, EliA Ro60Phadia ABK113610ANA-SCREEN WITH MDSSBio-Rad LaboratoriesK082759ELIA CENP IMMUNOASSAY, ELIA U1RNP IMMUNOASSAY, ELIA SM IMMUNOASSAY, ELIA RO IMMUNOASSAYPhadia US, Inc.K081104AESKULISA ANA HEP-2, REF 30-7115USAesku DiagnosticsK041658BIOPLEX 200 ANA SCREEN ON THE BIOPLEX 2200 MULTI-ANALYTE DETECTION SYSTEM, MODEL BIOPLEX 2200Bio-Rad Laboratories, Inc.K042416ATHENA MULTI-LYTE ANA-II TEST SYSTEMZeus Scientific, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑